A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses - PubMed (original) (raw)
. 2010 Oct 23;376(9750):1393-400.
doi: 10.1016/S0140-6736(10)61267-6.
Emmi Tikkanen, Marju Orho-Melander, Aki S Havulinna, Kaisa Silander, Amitabh Sharma, Candace Guiducci, Markus Perola, Antti Jula, Juha Sinisalo, Marja-Liisa Lokki, Markku S Nieminen, Olle Melander, Veikko Salomaa, Leena Peltonen, Sekar Kathiresan
Affiliations
- PMID: 20971364
- PMCID: PMC2965351
- DOI: 10.1016/S0140-6736(10)61267-6
A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses
Samuli Ripatti et al. Lancet. 2010.
Abstract
Background: Comparison of patients with coronary heart disease and controls in genome-wide association studies has revealed several single nucleotide polymorphisms (SNPs) associated with coronary heart disease. We aimed to establish the external validity of these findings and to obtain more precise risk estimates using a prospective cohort design.
Methods: We tested 13 recently discovered SNPs for association with coronary heart disease in a case-control design including participants differing from those in the discovery samples (3829 participants with prevalent coronary heart disease and 48,897 controls free of the disease) and a prospective cohort design including 30,725 participants free of cardiovascular disease from Finland and Sweden. We modelled the 13 SNPs as a multilocus genetic risk score and used Cox proportional hazards models to estimate the association of genetic risk score with incident coronary heart disease. For case-control analyses we analysed associations between individual SNPs and quintiles of genetic risk score using logistic regression.
Findings: In prospective cohort analyses, 1264 participants had a first coronary heart disease event during a median 10·7 years' follow-up (IQR 6·7-13·6). Genetic risk score was associated with a first coronary heart disease event. When compared with the bottom quintile of genetic risk score, participants in the top quintile were at 1·66-times increased risk of coronary heart disease in a model adjusting for traditional risk factors (95% CI 1·35-2·04, p value for linear trend=7·3×10(-10)). Adjustment for family history did not change these estimates. Genetic risk score did not improve C index over traditional risk factors and family history (p=0·19), nor did it have a significant effect on net reclassification improvement (2·2%, p=0·18); however, it did have a small effect on integrated discrimination index (0·004, p=0·0006). Results of the case-control analyses were similar to those of the prospective cohort analyses.
Interpretation: Using a genetic risk score based on 13 SNPs associated with coronary heart disease, we can identify the 20% of individuals of European ancestry who are at roughly 70% increased risk of a first coronary heart disease event. The potential clinical use of this panel of SNPs remains to be defined.
Funding: The Wellcome Trust; Academy of Finland Center of Excellence for Complex Disease Genetics; US National Institutes of Health; the Donovan Family Foundation.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Figures
Figure
Distributions at baseline of genetic risk score, LDL cholesterol, systolic blood pressure, and log-transformed C-reactive protein by 10-year incident coronary heart disease event status in FINRISK 1992 and 1997 cohorts Data for C-reactive protein only available in FINRISK 1997. CHD=coronary heart disease.
Comment in
- Genomic risk prediction.
Sandhu M, Wood A, Young E. Sandhu M, et al. Lancet. 2010 Oct 23;376(9750):1366-7. doi: 10.1016/S0140-6736(10)61921-6. Lancet. 2010. PMID: 20971347 No abstract available. - SNPs and coronary heart disease.
Kaczorowski J. Kaczorowski J. Lancet. 2011 Jan 29;377(9763):379; author reply 379-80. doi: 10.1016/S0140-6736(11)60124-4. Lancet. 2011. PMID: 21277436 No abstract available. - SNPs and coronary heart disease.
Simmonds M, Wald N. Simmonds M, et al. Lancet. 2011 Jan 29;377(9763):379; author reply 379-80. doi: 10.1016/S0140-6736(11)60123-2. Lancet. 2011. PMID: 21277437 No abstract available.
Similar articles
- Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease.
Mosley JD, Gupta DK, Tan J, Yao J, Wells QS, Shaffer CM, Kundu S, Robinson-Cohen C, Psaty BM, Rich SS, Post WS, Guo X, Rotter JI, Roden DM, Gerszten RE, Wang TJ. Mosley JD, et al. JAMA. 2020 Feb 18;323(7):627-635. doi: 10.1001/jama.2019.21782. JAMA. 2020. PMID: 32068817 Free PMC article. - A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study.
Thanassoulis G, Peloso GM, Pencina MJ, Hoffmann U, Fox CS, Cupples LA, Levy D, D'Agostino RB, Hwang SJ, O'Donnell CJ. Thanassoulis G, et al. Circ Cardiovasc Genet. 2012 Feb 1;5(1):113-21. doi: 10.1161/CIRCGENETICS.111.961342. Epub 2012 Jan 10. Circ Cardiovasc Genet. 2012. PMID: 22235037 Free PMC article. - Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohorts.
Hughes MF, Saarela O, Stritzke J, Kee F, Silander K, Klopp N, Kontto J, Karvanen J, Willenborg C, Salomaa V, Virtamo J, Amouyel P, Arveiler D, Ferrières J, Wiklund PG, Baumert J, Thorand B, Diemert P, Trégouët DA, Hengstenberg C, Peters A, Evans A, Koenig W, Erdmann J, Samani NJ, Kuulasmaa K, Schunkert H. Hughes MF, et al. PLoS One. 2012;7(7):e40922. doi: 10.1371/journal.pone.0040922. Epub 2012 Jul 25. PLoS One. 2012. PMID: 22848412 Free PMC article. Clinical Trial. - A multilocus genetic risk score predicts coronary heart disease risk in a Chinese Han population.
Gui L, Wu F, Han X, Dai X, Qiu G, Li J, Wang J, Zhang X, Wu T, He M. Gui L, et al. Atherosclerosis. 2014 Dec;237(2):480-5. doi: 10.1016/j.atherosclerosis.2014.09.032. Epub 2014 Oct 18. Atherosclerosis. 2014. PMID: 25463077 - Multilocus genetic risk scores for coronary heart disease prediction.
Ganna A, Magnusson PK, Pedersen NL, de Faire U, Reilly M, Arnlöv J, Sundström J, Hamsten A, Ingelsson E. Ganna A, et al. Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2267-72. doi: 10.1161/ATVBAHA.113.301218. Epub 2013 May 16. Arterioscler Thromb Vasc Biol. 2013. PMID: 23685553
Cited by
- Differential prediction performance between Caribbean- and Mainland-subgroups using state-of-the-art polygenic risk scores for coronary heart disease: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Hutten CG, Boehm FJ, Smith JA, Spitzer BW, Wassertheil-Smoller S, Isasi CR, Cai J, Unkart JT, Sun J, Persky V, Daviglus ML, Sofer T, Argos M. Hutten CG, et al. medRxiv [Preprint]. 2024 Sep 27:2024.09.25.24313663. doi: 10.1101/2024.09.25.24313663. medRxiv. 2024. PMID: 39399039 Free PMC article. Preprint. - Genetic Risk Score for Prediction of Coronary Heart Disease in the Korean Genome and Epidemiology Study.
Yun H, Lim JE, Lee EY. Yun H, et al. Rev Cardiovasc Med. 2023 Apr 4;24(4):102. doi: 10.31083/j.rcm2404102. eCollection 2023 Apr. Rev Cardiovasc Med. 2023. PMID: 39076255 Free PMC article. - Going from Primary to Primordial Prevention: Is the Juice Worth the Squeeze?
Chiou A, Hermel M, Chai Z, Eiseman A, Jeschke S, Mehta S, Khan U, Hoodbhoy Z, Safdar N, Khoja A, Junaid V, Vaughan E, Merchant AT, Iqbal J, Almas A, Virani SS, Sheikh S. Chiou A, et al. Curr Cardiol Rep. 2024 Oct;26(10):1135-1143. doi: 10.1007/s11886-024-02109-3. Epub 2024 Jul 29. Curr Cardiol Rep. 2024. PMID: 39073507 Review. - Cardiovascular Disease Prevalence in Asians Versus Americans: A Review of Genetics, Diet, and the Call for Enhanced Prevention and Screening.
Nammi JY, Pasala R, Kotaru S, Bandikolla SS, Andhe N, Gouravaram PR. Nammi JY, et al. Cureus. 2024 Apr 16;16(4):e58361. doi: 10.7759/cureus.58361. eCollection 2024 Apr. Cureus. 2024. PMID: 38756312 Free PMC article. Review. - Smoking timing, genetic susceptibility and the risk of incident type 2 diabetes: A cohort study from the UK Biobank.
Hu Y, Li X, Wang X, Ma H, Zhou J, Tang R, Kou M, Heianza Y, Liang Z, Qi L. Hu Y, et al. Diabetes Obes Metab. 2024 Jul;26(7):2850-2859. doi: 10.1111/dom.15603. Epub 2024 Apr 15. Diabetes Obes Metab. 2024. PMID: 38618988
References
- Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J., 3rd Factors of risk in the development of coronary heart disease—six year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33–50. - PubMed
- Musunuru K, Kathiresan S. Genetics of coronary artery disease. Annu Rev Genomics Hum Genet. 2010;11:91–108. - PubMed
- Healy DG. Case-control studies in the genomic era: a clinician's guide. Lancet Neurol. 2006;5:701–707. - PubMed
- Vartiainen E, Laatikainen T, Peltonen M. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol. 2009;12:1–15. - PubMed
- Kattainen A, Salomaa V, Härkänen T. Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s. Eur Heart J. 2006;27:296–301. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 HL087676/HL/NHLBI NIH HHS/United States
- WT089061/Z/09/Z/WT_/Wellcome Trust/United Kingdom
- (R01 HL087676/HL/NHLBI NIH HHS/United States
- WT089062/Z/09/Z/WT_/Wellcome Trust/United Kingdom
- WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources